The global ophthalmic viscosurgical devices market size is expected to reach around US$ 876.3 Mn by 2026, growing at a CAGR of around 9.7% from forecast period 2019 to 2026.
Ophthalmic viscosurgical devices are used in ophthalmic surgery for maintaining the anterior chamber during surgical maneuvers. The main function of ophthalmic viscosurgical devices are to maintain and preserve space, displace and stabilize tissue, and coat and protect tissue. Based on product type, different types of ophthalmic viscosurgical devices such as dispersive ophthalmic viscosurgical devices and cohesive ophthalmic viscosurgical devices are used. According to world Health Organization (WHO) in 2017, more than 285 million people across the globe have vision impairment, and 42% due to uncorrected refractive errors. Ophthalmic viscosurgical devices are necessary for anterior segment surgeon. According to WHO, There are about 1 billion individuals, which is nearly 13.46% of the global population, suffering from neurological disorders and more than 350 million people are suffering from depression.
Market Dynamics
The growth of the ophthalmic viscosurgical devices market is primarily driven by the rising ophthalmic viscosurgical devices demand from cataract surgeries, glucoma surgeries, and other surgeries applications, increase in geriatric population across the globe, and technological advancements in ophthalmic viscosurgical devices. Furthermore, increase in demand and preference for non-invasive treatment and expanding base of diabetic patients worldwide, is estimated to boost the market growth. Moreover, changing lifestyles of consumers across developed countries, growing pharmaceutical and medical industry, technological advancement and increase in the number of applications are expected to create opportunities for the manufacturers in the global market over the forecast period. However, high cost of ophthalmic devices and risks associated with eye surgeries are expected to hamper the growth of the global ophthalmic viscosurgical devices market in the coming years.
By product type, dispersive OVD dominated the ophthalmic viscosurgical devices market
The dispersive OVD segment accounted for approximately 54% of the share in the global ophthalmic viscosurgical devices market in 2018. Increase in demand for surgical aid for performing ocular surgeries such as cataract, glaucoma, vitrectomy, and others, creating and maintaining space in anterior segment of the eye at the time of surgery, and rising incidences of various diseases is further expected to raise segment over the forecast period.
By end-use, hospitals segment dominated the ophthalmic viscosurgical devices market
The hospitals segment accounted for approximately 41% of the share in the global ophthalmic viscosurgical devices market in 2018. Growing demand for multi-specialty medical devices for vision correction and cataract procedures and growing consumer preference towards technology advanced surgical procedures performed in hospitals is further expected to raise segment over the forecast period. Owing to its growing number of surgery, growing number of devices requirement in hospitals, and supportive government initiatives for ophthalmic viscosurgical devices in hospitals further grows the demand for ophthalmic viscosurgical devices in hospitals applications during the forecast period.
By application, cataract surgeries segment dominated the ophthalmic viscosurgical devices market
The cataract surgeries segment accounted for approximately 44% of the share in the global ophthalmic viscosurgical devices market in 2018. Geriatric population across the globe and growing incidence of cataract, and rising demand for safe surgery is further expected to raise segment over the forecast period.
The market research study on “Ophthalmic Viscosurgical Devices Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight into the global ophthalmic viscosurgical devices market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global ophthalmic viscosurgical devices market, its product type, application, end-use, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global ophthalmic viscosurgical devices market size and volume, and segment markets by product type, application, end-use, and geography along with the information on companies operating in the market. The ophthalmic viscosurgical devices market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
In 2018, North America dominated the regional market with a maximum market share
North America accounted for the high market share of the ophthalmic viscosurgical devices market and the region is also expected to maintain its dominance over the forecast period. The region is experiencing the maximum growth owing to the rapid consumption of ophthalmic viscosurgical devices in various end user applications, presence of ophthalmic viscosurgical devices companies, favorable reimbursement policies, and rapidly growing geriatric population. Highly efficient reimbursement structure and developed healthcare infrastructure in the North America region is one of the key factors driving the consumption of ophthalmic viscosurgical devices in this region. Moreover, highly skilled neurosurgeons, growing number of hospitals and research centers in key countries such as US and Canada are also propelling the growth of ophthalmic viscosurgical devices in the North America region. Europe is followed by the North America region in the ophthalmic viscosurgical devices market.
Asia-Pacific is expected to hold the highest CAGR in the global market during the forecast period. The growing medical device industry, increase in innovation and development in ophthalmic viscosurgical devices, and growing geriatric populations, are expected to enhance the market growth in the global thermal interface materials market during the forecast.
The players profiled in the report include Carl Zeiss Meditec AG, Alcon Laboratories, Abbott Medical Optics Inc., Bausch & Lomb, Inc., Lifecore Biomedical, LLC, Rumex International Company, EyeKon Medical, Inc., Amring pharmaceutical Inc, Bohus Biotech AB, and Sidapharm among others. The companies are involved in mergers and acquisitions and new product development for expanding their market share and also for gaining competitive advantages over its competitors.
Market Segmentation
Market By Product Type
- Dispersive OVD
- Cohesive OVD
Market By Application
- Cataract surgeries
- Glucoma surgeries
- Others
Market By End-use
- Hospital
- Clinics
- Ophthalmology clinic
- Others
Market By Geography
- North America
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Ophthalmic Viscosurgical Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Ophthalmic Viscosurgical Devices Market By Application
1.2.2.1. Global Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.2.2. Global Ophthalmic Viscosurgical Devices Market Revenue Share By Application in 2018
1.2.2.3. Cataract Surgeries
1.2.2.4. Glucoma Surgeries
1.2.2.5. Others
1.2.3. Ophthalmic Viscosurgical Devices Market By Product Type
1.2.3.1. Global Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.3.2. Global Ophthalmic Viscosurgical Devices Market Revenue Share By Product Type in 2018
1.2.3.3. Dispersive OVD
1.2.3.4. Cohesive OVD
1.2.4. Ophthalmic Viscosurgical Devices Market By End-Use
1.2.4.1. Global Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.4.2. Global Ophthalmic Viscosurgical Devices Market Revenue Share By End-Use in 2018
1.2.4.3. Hospitals
1.2.4.4. Dental Clinics
1.2.4.5. Others
1.2.5. Ophthalmic Viscosurgical Devices Market by Geography
1.2.5.1. Global Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Ophthalmic Viscosurgical Devices Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Ophthalmic Viscosurgical Devices Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Ophthalmic Viscosurgical Devices Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Ophthalmic Viscosurgical Devices Major Manufacturers in 2018
CHAPTER 4. OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY Application
4.1. Global Ophthalmic Viscosurgical Devices Revenue By Application
4.2. Cataract Surgeries
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Glucoma Surgeries
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY PRODUCT TYPE
5.1. Global Ophthalmic Viscosurgical Devices Revenue By Product Type
5.2. Dispersive OVD
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cohesive OVD
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY END-USE
6.1. Global Ophthalmic Viscosurgical Devices Revenue By End-Use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Dental Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY COUNTRY
7.1. North America Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Ophthalmic Viscosurgical Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Ophthalmic Viscosurgical Devices Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY COUNTRY
8.1. Europe Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Ophthalmic Viscosurgical Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Ophthalmic Viscosurgical Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY COUNTRY
10.1. Latin America Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Ophthalmic Viscosurgical Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY COUNTRY
11.1. Middle East Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Ophthalmic Viscosurgical Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
CHAPTER 12. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET BY COUNTRY
12.1. Africa Ophthalmic Viscosurgical Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Ophthalmic Viscosurgical Devices Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Carl Zeiss Meditec AG
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Alcon Laboratories
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Abbott Medical Optics Inc
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bausch & Lomb
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Lifecore Biomedical, LLC
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Rumex International Company
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. EyeKon Medical, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Amring pharmaceutical Inc
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Bohus Biotech AB
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Sidapharm
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. Key Developments
13.10.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope